ImmunityBio, Inc. (IBRX)
1.98
0.00 (0.00%)
USD |
NASDAQ |
Dec 31, 16:00
1.99
+0.01
(+0.51%)
After-Hours: 20:00
ImmunityBio Market Cap: 1.950B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioCryst Pharmaceuticals, Inc. | 1.642B |
| Corcept Therapeutics, Inc. | 3.661B |
| Cytokinetics, Inc. | 7.769B |
| Relay Therapeutics, Inc. | 1.466B |
| Moderna, Inc. | 11.52B |
Market Cap Related Metrics
| PS Ratio | 20.52 |
| Price | 1.98 |
| Earnings Yield | -21.24% |